Mechanical engineering / Tekijä 406081 Parmar, M. S., Sarao, A. S.

Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots. Tekijä Royston, P, Parmar, M, Altman, D

Re: Visualizing length of survival in time-to-event studies: A complement to Kaplan-Meier plots - Response Tekijä Royston, P, Parmar, M, Altman, D

Combined test versus logrank/Cox test in 50 randomised trials Tekijä Royston, P, Choodari-Oskooei, B, Parmar, M, Rogers, J

The DURATIONS randomised trial design: estimation targets, analysis methods and operating characteristics Tekijä Quartagno, M, Carpenter, JR, Walker, AS, Clements, M, Parmar, M

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Tekijä Sydes, MR, Altman, D, Babiker, AB, Parmar, M, Spiegelhalter, D

Bayesian stopping rules for trials - Reply Tekijä Parmar, M, Spiegelhalter, D, Griffiths, G, Altman, D, Souhami, R

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Tekijä Sydes, MR, Spiegelhalter, D, Altman, D, Babiker, AB, Parmar, M

Evaluating many treatments and biomarkers in oncology: a new design. Tekijä Kaplan, R, Maughan, T, Crook, A, Fisher, D, Wilson, R, Brown, L, Parmar, M

Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Tekijä Parmar, M, Griffiths, G, Spiegelhalter, D, Souhami, R, Altman, D, van der Scheuren, E

Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Tekijä Vale, C, Tierney, J, Fisher, D, Adams, R, Kaplan, R, Maughan, T, Parmar, M, Meade, A

Impact of K-ras status on the effects of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): A systematic review and meta-analysis of randomized c... Tekijä Vale, C, Tierney, J, Meade, A, Fisher, D, Kaplan, R, Adams, R, Maughan, T, Parmar, M

A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RA... Tekijä Vale, C, Tierney, J, Meade, A, Fisher, D, Kaplan, R, Adams, R, Maughan, T, Parmar, M

Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis Tekijä Vale, C, Tierney, J, Fisher, D, Adams, R, Kaplan, R, Maughan, T, Parmar, M, Meade, A

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Tekijä Seymour, M, Thompson, L, Wasan, H, Middleton, G, Brewster, A, Shepherd, S, O'Mahony, MS, Maughan, T, Parmar, M, Langley, R

Kinetic cross-modal correspondences and felt (e)motion in a novel set of musical stimuli Tekijä Kolesnikov, A, Bamford, JS, Andrade, E, Montalti, M, Calbi, M, Langiulli, N, Parmar, M, Guerra, M, Gallese, V, Umiltà, MA

Cancer Drugs Fund requires further reform Tekijä Grieve, R, Abrams, K, Claxton, K, Goldacre, B, James, N, Nicholl, J, Parmar, M, Parker, C, Sekhon, J, Smeeth, L, Spiegelhalter, D, Sculpher, M

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Tekijä Seymour, M, Maughan, T, Ledermann, J, Topham, C, James, R, Gwyther, S, Smith, D, Shepherd, S, Maraveyas, A, Ferry, DR, Meade, A, Thompson, L, Griffiths, G, Parmar, M, Stephens, R

Issues in data monitoring and interim analysis of trials. Tekijä Grant, A, Altman, D, Babiker, AB, Campbell, M, Clemens, F, Darbyshire, J, Elbourne, DR, McLeer, S, Parmar, M, Pocock, S, Spiegelhalter, D, Sydes, MR, Walker, A, Wallace, SA

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease Tekijä Foltynie, T, Gandhi, S, Gonzalez-Robles, C, Zeissler, M-L, Mills, G, Barker, R, Carpenter, J, Schrag, A, Schapira, A, Bandmann, O, Mullin, S, Duffen, J, Tofaris, GK, McFarthing, K, Chataway, J, Parmar, M, Carroll, C